Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.

Saved in:
Bibliographic Details
Title: Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.
Authors: Tarshish P; Albert Einstein College of Medicine, Bronx, New York, USA., Tobin JN, Bernstein J, Edelmann CM Jr
Source: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 1996 Oct; Vol. 10 (5), pp. 590-3.
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print Cited Medium: Print ISSN: 0931-041X (Print) Linking ISSN: 0931041X NLM ISO Abbreviation: Pediatr Nephrol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0931-041X
DOI:10.1007/s004670050167